Kelly Meijsen, BASc

Method transfer coordinator Xchange at Viroclinics Biosciences BV
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
The Randstad, Netherlands, NL
Languages
  • Nederlands -
  • Engels -

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Credentials

  • Artikel 6B WOD
    Hogeschool Rotterdam
    Jun, 2017
    - Nov, 2024
  • BASc
    Hogeschool Rotterdam
    Jul, 2015
    - Nov, 2024
  • EFSET 64 Advanced (CEFR C1)
    EF Education First

Experience

    • Netherlands
    • Biotechnology Research
    • 200 - 300 Employee
    • Method transfer coordinator Xchange
      • Sep 2021 - Present

    • Netherlands
    • Hospitals and Health Care
    • 700 & Above Employee
    • Research Technician
      • Jul 2015 - Jul 2021

      Cystic FibrosisTechniques: Organoids culture, FIS assay, Western Blot, Cell culture, Ussing chamber, Gel electrophoresis and (q)PCR.

    • Afstudeerstudent
      • Nov 2014 - Jun 2015

      Title: The function of miR-126 and its response to chemotherapy and survival in esophageal adenocarcinomaTechniques: qPCR, FACS, MTT and Cell cultureGrade: 8/10

    • Netherlands
    • Retail
    • 700 & Above Employee
    • Medewerkster informatiebalie en cassière
      • Mar 2010 - Jan 2016

    • France
    • Research Services
    • 700 & Above Employee
    • Student
      • Aug 2013 - Jan 2014

      Title: Neocate: The Next generation. Effects of X1/X2/Y on the immune system Techniques: ELISA, Histology, Fatty acid profiling and Cell culture Title: Neocate: The Next generation. Effects of X1/X2/Y on the immune system Techniques: ELISA, Histology, Fatty acid profiling and Cell culture

Education

  • Hogeschool Rotterdam
    Bachelor of Applied Science (B.A.Sc.), Life Sciences
    2012 - 2015
  • Dalton Lyceum Barendrecht
    VWO, NT & NG
    2006 - 2012

Community

You need to have a working account to view this content. Click here to join now